Skip to footer

politics

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Updated 1 min read

Archived — last updated

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.

Latest updates

No updates on this story yet.

Topics